Download a sample of confirmed delegates 2012 – Proceed here
TO SEE DETAILED BREAKDOWN OF TOPICS PLEASE REQUEST THE FULL PDF AGENDA.
STREAM A:
SFE, CRM, KAM, remodeling the sales force, new digital sales channels and new
technologies and more…
STREAM B:
Advanced sales training, developing extra skills for achieving superior performance, metrics and measuring sales performance and more…
DAY 1 OVERVIEW – 28th February 2012
SESSION 1: RESHAPING PHARMA SALES FORCES FOR SUCCESS
Key topic:
- KEYNOTE PRESENTATION: Remodelling the sales force – Is there a perfect sales model?
- CASE STUDY: Implementation of new commercial model – making it work
- What are the channels and media preferred by our customers for interaction?
and others…
SESSION 2: KEY ACCOUNT MANAGEMENT AS A SALES MODEL OF CHOICE (STREAM A)
Two hours of CASE STUDIES and discussions include:
- CASE STUDY: The organization of Key-Account- Management and sales forces in hospital-business
To reveal all topics and speakers in this session – Request the PDF agenda.
SESSION 3: ENHANCING SFE THROUGH EFFECTIVE CRM AND SFA TECHNIQUES (STREAM A)
-
Two hours of CASE STUDIES and interactive discussions.
Reveal the topics and speakers in this session – Request the PDF agenda.
SESSION 4: DEVELOPING & MAINTAINING HIGH-PERFORMING SALES FORCES (STREAM B)
- SIMULATION PRESENTATION: Introducing our new Sales training & development program
- Cornerstones of effective sales training and development
SESSION 5: MEASURING AND INCENTIVIZING SALES PERFORMANCE (STREAM B)
-
Almost two hours of CASE STUDIES
Detailed topic breakdown is in the PDF brochure.
DAY 2 OVERVIEW – 29th February 2012
SESSION 6: UTILIZING DIGITAL TOOLS & SOCIAL MEDIA TO IMPROVE SFE (STREAM A)
- CASE STUDY: Launching new YouTube channel to enhance SFE
- Interactive CASE STUDY: Is closed-loop multichannel marketing really possible in the pharma industry, and where does the Sales Rep fit in?
SPECIAL 3 HOUR SESSION: PRACTICAL CASE STUDIES ON ACHIEVING SFE IN SPECIFIC MARKETS OR PRODUCTS
- CASE STUDY: Customized sales model for specialty and orphan drugs.
- CASE STUDY:Sales tactics to boost sales of older drugs.
- CASE STUDY: Structuring sales forces for emerging markets.
- PANEL DISCUSSION: Dialogue focused model Interacting with new customers – payers and governments.
There are 4 additional CASE STUDIES, 2 Interactive debates and 2 Q&A Sessions on the Day 2.



